Compare Aurora Cannabis Inc (ACB) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs PepsiCo, Inc. — how do they compare? Aurora Cannabis Inc trades at $2.66 (market cap $165.36M), while PepsiCo, Inc. trades at $144.01 (market cap $198.15B). The key difference: PepsiCo, Inc. is far larger — about 1198.3× Aurora Cannabis Inc's market cap, and PepsiCo, Inc. pays a 4.08% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | PEP | |
|---|---|---|
Market Cap | $165.36M | $198.15B |
Sector | Health | Consumer Staples |
52-Week High | $6.23 | $170.44 |
52-Week Low | $2.67 | $133.81 |
Enterprise Value | $99.82M | $240.05B |
Dividend Yield | — | 4.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
PepsiCo (PEP) trades at $144.6, up 0.91% on the day, with a bullish technical signal and recent earnings beats. The stock shows strong profitability with a 9.15% net margin and 43.92% ROE, though revenue growth remains modest at 2.2% year-over-year. Recent news highlights price cuts on snacks after consumer pushback on high prices, while the company prepares for Q1 2026 earnings next week.
The outlook is cautiously optimistic with a consensus price target of $161.73 (12% upside). Analyst sentiment leans neutral (63.64% Hold), balancing strong cash flow and brand power against pricing pressures and modest growth. Key risks include execution of North America turnaround and consumer sensitivity to price hikes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
